Gordon Sanghera was co-founder of Oxford Nanopore, together with Hagan Bayley and IP Group. He was appointed CEO in June 2005 having acted as a consultant since February 2005 whilst the Company was established. He brings over 15 years experience in the design, development and global launch of novel point-of-care biosensor devices. At Abbott Laboratories, Dr Sanghera held both UK and US Director level positions, including Research Director and Manufacturing Process Development Director. Before its acquisition by Abbott, Gordon led the R&a;D of Medisense Inc. where he was instrumental in the launch of several generations of blood glucose biosensor systems for the consumer and medical markets. He has also developed and validated market production processes to meet with the regulatory requirements for USA and Europe. Gordon has a DPhil in biosensor technology and a degree in Chemistry.
Gordon Sanghera is the co-founder of Oxford Nanopore, a biosensor technology company based in the United Kingdom. With over 15 years of experience, he has played a key role in the design, development, and global launch of new point-of-care biosensor devices. Prior to his current role, he held senior positions at Abbott Laboratories and Medisense Inc., where he played a key role in the launch of blood glucose biosensor systems for the consumer and medical markets. Gordon has a DPhil in biosensor technology and a degree in Chemistry.
We found 1 Gordon Sanghera's email addresses
We found 1 Gordon Sanghera's phone numbers
Gordon Sanghera works for Oxford Nanopore Technologies
Gordon Sanghera's role in Oxford Nanopore Technologies is Chief Executive Officer | Co-Founder
Gordon Sanghera's latest job experience is Chief Executive Officer | Co-Founder at Oxford Nanopore Technologies